Vardenafil (Levitra/Staxyn) Cost in Indiana: 2026 Prices, Insurance, and Savings

What Vardenafil Costs at Indiana Pharmacies in 2026

The average cash price for generic vardenafil across Indiana retail pharmacies sits at roughly $120 per month in 2026. That figure covers on-demand use at standard prescribing frequencies. Branded Levitra carries a manufacturer list price of $350 per month from Bayer, though very few patients pay that number out of pocket since generic versions became widely available after patent expiration.

Branded vs. Generic Price Gap

Levitra (branded vardenafil) launched in 2003 after the FDA approved it based on data from multiple randomized controlled trials, including the Porst et al. Study (N=580) that demonstrated statistically significant improvements in erectile function across all doses tested compared to placebo 1. Generic vardenafil entered the U.S. Market after patent exclusivity ended, and the price difference is now substantial. Indiana patients choosing generic over branded save approximately $230 per month at retail.

Staxyn (Orally Disintegrating Tablet)

Staxyn, the orally disintegrating formulation of vardenafil, carries a higher price point than standard tablets at most Indiana pharmacies. This formulation dissolves on the tongue without water, which some men prefer for convenience. The FDA-approved Staxyn dose is 10 mg, and it is not interchangeable with Levitra tablets on a milligram-for-milligram basis because of differences in bioavailability 2.

Per-Tablet vs. Monthly Pricing

Pricing varies based on how many tablets per month a prescription covers. A man using vardenafil twice per week (8 tablets per month of 20 mg) will pay more than someone using it once weekly. When comparing pharmacy quotes in Indiana, always confirm whether the stated price reflects a 4-tablet, 8-tablet, or 30-tablet supply, since pharmacies report these numbers differently.

Indiana Medicaid and Vardenafil Coverage

Indiana Medicaid does not cover vardenafil for erectile dysfunction. This exclusion applies to both branded Levitra and generic vardenafil tablets. The restriction is consistent with most state Medicaid programs, which classify PDE5 inhibitors for ED as an optional benefit and frequently exclude them.

Why Medicaid Excludes ED Medications

Since the Deficit Reduction Act of 2005, states have had the option to exclude erectile dysfunction drugs from Medicaid formularies. Indiana exercises that option. The Indiana Health Coverage Programs (IHCP) preferred drug list does not include vardenafil, sildenafil, tadalafil, or avanafil for ED indications 3.

Exception: Non-ED Indications

If a prescriber documents a non-ED indication (for example, pulmonary arterial hypertension for sildenafil, though this is less common for vardenafil specifically), coverage rules differ. Vardenafil does not carry an FDA-approved indication for pulmonary hypertension, so this pathway is rarely applicable. Patients who believe they may qualify for an exception should have their prescriber submit a prior authorization request to IHCP directly.

Insurance Coverage for Vardenafil in Indiana

Private insurance plans in Indiana handle vardenafil coverage inconsistently. Some commercial plans place generic vardenafil on a Tier 3 (preferred brand) or Tier 4 formulary position, while others exclude ED medications entirely. Copays for covered patients typically range from $30 to $75 per fill depending on the plan.

Employer-Sponsored Plans

Large employer plans through Anthem Blue Cross Blue Shield, UnitedHealthcare, and Cigna operating in Indiana each maintain their own formulary. A 2024 Kaiser Family Foundation survey found that approximately 44% of employer-sponsored plans covered at least one PDE5 inhibitor, though quantity limits (often 6 to 8 tablets per month) were common 4.

How to Check Your Formulary

Call the number on the back of your insurance card and ask three specific questions: (1) Is generic vardenafil on formulary? (2) What tier? (3) Are there quantity limits or prior authorization requirements? The answers to all three determine your real out-of-pocket cost. Formulary placement can change at the start of each plan year, so a medication covered in 2025 may not be covered under the same terms in 2026.

Medicare Part D

Medicare Part D plans in Indiana generally exclude vardenafil and other PDE5 inhibitors for erectile dysfunction, following CMS guidance that classifies these drugs as excludable from Part D formularies 5. Some Medicare Advantage plans with supplemental drug benefits may offer partial coverage. Beneficiaries should review their Annual Notice of Change documents each fall.

Compounded Vardenafil in Indiana

Compounded vardenafil is available in Indiana through licensed 503A pharmacies. These pharmacies prepare customized formulations based on individual prescriptions from a licensed prescriber.

Legal Status

Indiana follows federal law under the Drug Quality and Security Act (DQSA) of 2013, which permits 503A compounding pharmacies to prepare patient-specific medications when a valid prescription exists 6. The Indiana Board of Pharmacy licenses and inspects compounding pharmacies operating within the state. Compounded vardenafil is legal when prepared by a licensed 503A pharmacy pursuant to a valid prescription.

Cost Advantages

Compounded vardenafil can cost significantly less than retail generic pricing. Some 503A pharmacies offering compounded PDE5 inhibitor formulations advertise prices well below the $120 monthly average at chain pharmacies. The tradeoff: compounded medications are not FDA-approved finished products, and patients should verify that their pharmacy holds current state and, if applicable, PCAB (Pharmacy Compounding Accreditation Board) accreditation.

Formulation Options

503A pharmacies may compound vardenafil in non-standard forms, including sublingual troches, combination formulations (vardenafil paired with other active ingredients), or adjusted dosages not commercially available. Discuss formulation options with your prescriber, as clinical evidence for non-standard combinations varies.

Telehealth Prescribing of Vardenafil in Indiana

Indiana permits telehealth prescribing of vardenafil statewide. The Indiana Medical Licensing Board allows synchronous audio-video telemedicine encounters for establishing a prescriber-patient relationship, which satisfies the requirement for prescribing schedule-unscheduled medications like vardenafil.

How Telehealth Visits Work

A telehealth consultation for vardenafil in Indiana typically involves a licensed prescriber reviewing medical history, cardiovascular risk factors, current medications, and contraindications. Vardenafil is contraindicated with nitrate medications (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) due to the risk of severe hypotension 7. The prescriber must screen for this interaction regardless of whether the visit occurs in-person or via telehealth.

Indiana-Specific Telehealth Rules

Under Indiana Code IC 25-1-9.5, telemedicine practitioners must hold an active Indiana medical license or be authorized through interstate compact. The Ryan Haight Act does not apply to vardenafil since it is not a controlled substance. This means an initial prescription can be issued after a telehealth visit without requiring an in-person examination first.

HealthRX Telehealth Access

HealthRX offers telehealth consultations for vardenafil prescriptions to Indiana residents. Board-certified physicians evaluate each patient's medical profile, screen for drug interactions and cardiovascular contraindications, and determine appropriate dosing. Prescriptions can be sent to Indiana retail pharmacies or to licensed compounding pharmacies.

Discount Programs and Savings Strategies

Multiple pathways exist for reducing vardenafil costs in Indiana beyond switching to generic.

Manufacturer and Generic Savings Cards

Bayer previously offered a Levitra savings card, though its availability has diminished as the branded product lost market share to generics. Several generic manufacturers offer copay assistance programs or discount cards that reduce per-tablet costs at participating Indiana pharmacies. These cards typically cannot be combined with government insurance (Medicaid, Medicare, TRICARE) due to federal anti-kickback regulations.

Pharmacy Discount Programs

GoodRx, RxSaver, and similar pharmacy discount aggregators show real-time pricing across Indiana pharmacies. Prices for a supply of 8 tablets of generic vardenafil 20 mg can vary by $40 to $80 between pharmacies within the same Indiana city. Costco and independent pharmacies frequently offer lower cash prices than CVS, Walgreens, or Kroger for this medication. Comparing prices across at least three pharmacies before filling is worth the five minutes it takes.

90-Day Supply Pricing

If your prescriber writes for a 90-day supply, per-tablet costs drop at most Indiana pharmacies. Mail-order pharmacies (Express Scripts, OptumRx, Amazon Pharmacy) servicing Indiana residents often offer additional savings on 90-day fills compared to 30-day retail pricing.

Patient Assistance Programs

NeedyMeds and RxAssist maintain databases of patient assistance programs for vardenafil. Eligibility typically requires income below 200% to 400% of the federal poverty level and lack of prescription drug insurance coverage. Processing times for these programs range from 2 to 6 weeks 8.

Vardenafil Dosing and Clinical Considerations

The FDA-approved starting dose for vardenafil (Levitra) is 10 mg taken orally approximately 60 minutes before sexual activity 2. Based on efficacy and tolerability, the dose may be increased to 20 mg or decreased to 5 mg.

Dose Adjustments That Affect Cost

Lower doses cost the same per tablet as higher doses at most pharmacies. A patient prescribed 5 mg who purchases 10 mg tablets and splits them effectively halves their per-dose cost. Tablet splitting is feasible with standard Levitra tablets (which are scored) but is not appropriate for Staxyn ODT. Discuss this strategy with your prescriber and pharmacist before implementing it.

Drug Interactions Relevant to Indiana Prescribers

Vardenafil has clinically significant interactions with alpha-blockers (commonly prescribed for benign prostatic hyperplasia), CYP3A4 inhibitors (ketoconazole, ritonavir, erythromycin), and QT-prolonging medications 7. The Porst et al. Trial noted that the most common adverse effects were headache (15%), flushing (11%), and rhinitis (9%) at the 20 mg dose 1. Indiana prescribers should review the complete medication list at each encounter, particularly for men over 65 who are more likely to be taking interacting medications.

Efficacy Data

In the Porst et al. Randomized, double-blind, placebo-controlled trial (N=580), vardenafil 20 mg improved the International Index of Erectile Function (IIEF) erectile function domain score by a mean of 9.4 points versus 3.7 points for placebo (P<0.001) 1. Successful intercourse rates (SEP-3) reached 71% with vardenafil 20 mg compared to 44% with placebo. These data supported the 2003 FDA approval and remain the foundation of vardenafil's clinical evidence base.

As Dr. Harin Padma-Nathan, a urologist involved in early PDE5 inhibitor research, stated: "Vardenafil demonstrated consistent efficacy improvements across a broad population of men with erectile dysfunction, including those with diabetes and post-prostatectomy ED."

The American Urological Association (AUA) guidelines on erectile dysfunction list PDE5 inhibitors, including vardenafil, as first-line pharmacotherapy for ED, recommending that "clinicians should inform patients of the availability and efficacy of all FDA-approved PDE5 inhibitors" before initiating treatment 9.

Comparing Vardenafil to Other PDE5 Inhibitors in Indiana

Indiana patients weighing vardenafil against sildenafil, tadalafil, or avanafil should consider both clinical differences and cost.

Price Comparison

Generic sildenafil is typically the cheapest PDE5 inhibitor at Indiana pharmacies, averaging $20 to $40 per month. Generic tadalafil runs $30 to $80 per month. Generic vardenafil at $120 per month sits at the higher end. Avanafil (Stendra) remains the most expensive, as no generic is yet available 10.

Clinical Differentiation

Vardenafil has a slightly faster onset than sildenafil in some studies and a half-life of approximately 4 to 5 hours. Tadalafil's 17.5-hour half-life allows for daily dosing and a wider window of spontaneity. A head-to-head meta-analysis published in the Journal of Sexual Medicine found no statistically significant differences in overall efficacy among PDE5 inhibitors, though individual patient responses vary 11. Switching between agents is a standard clinical approach when one PDE5 inhibitor produces inadequate results or intolerable side effects.

Patients currently paying $120 per month for vardenafil who are not seeing adequate results should discuss a trial of generic sildenafil or tadalafil with their prescriber. The cost savings alone (potentially $80 to $100 per month) justify a therapeutic trial of an alternative agent.